Dosimetry sales will expand through 2035, with personal electronic dosimeters at 61.3% within the product type segment and wearable dosimeters at 67.2% of the modality category in 2025. The market was valued at USD 3.28 billion in 2025 and is forecast to record a 4.5% CAGR between 2025 and 2035.